Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08.
Saved in:
| Title: | Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08. |
|---|---|
| Authors: | Pogue-Geile, Kay1, Yothers, Greg1,2,3, Yusuke Taniyama1, Noriko Tanaka1, Gavin, Patrick1, Colangelo, Linda1,2,3, Blackmon, Nicole1, Lipchik, Corey1, Seong Rim Kim1, Sharif, Saima1,4, Allegra, Carmen1,5, Petrelli, Nicholas1,6, O'Connell, Michael J.1, Wolmark, Norman1,4, Soonmyung Paik1,7 soon.paik@nsabp.org |
| Source: | JNCI: Journal of the National Cancer Institute. 7/3/2013, Vol. 105 Issue 13, p989-992. 4p. 1 Chart, 1 Graph. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
